Sibutsetelo
Iberogast® iyi-over-the-counter herbal formulation enokucwaninga okuningi okusekela ukusizakala kwayo ekunciphiseni izimpawu zokusebenza kwe- dyspepsia (FD) kanye nesifo se-bowel syndrome (IBS) esicasulayo . Iberogast® isetshenziswe iminyaka engaphezu kwamashumi amahlanu. Kungacatshangwa ngokuthi "ukuhlanganiswa kwe-bitters," ukuhlukumeza emuva esikhathini lapho ama-bitters asetshenziselwa kakhulu njengezinsiza zokugaya.
Iberogast® lakhiwa izwe laseJalimane (Steigerwald Arzneimittelwerk GmbH) futhi litholakala ngaphandle kwemithi emhlabeni jikelele.
Lapha uzothola konke mayelana nokuphepha nokusebenza kwe-Iberogast® ukuze wenze isinqumo esinolwazi sokuthi kungabe kuyinto enhle yini ukuthi uzame njengoba uzama ukuphatha izimpawu zakho ze-IBS .
Izithako
Iberogast® (eyaziwa ngokuthi i-STW 5 ezihlokweni zocwaningo) iyilungiselelo le-liquid eliqukethe amakhambi ayisishiyagalolunye:
- Candytuft enzima (i-Iberis amara totalis iyabuya)
- Isimpande se-angellica esomile (i-Angelicae radix)
- Inhloko yembali ye-chamomile eyomile (iMatricariae flos)
- Izithelo ezinomile ezimiweyo - ngokuvamile ezibizwa ngokuthi imbewu (i-Carvi fructus)
- Ubisi inhlanzi isithelo omisiwe (Silybi mariani fructus)
- Iqabunga elimile elomile (Melissae folium)
- Iqabunga elomile le-peppermint (Menthae piperitae folium)
- I-celandine eyomile (i-Chelidonii herba)
- Izimpande ezomile zotshwala (Liquiritiae radix)
Imiphumela
Ukucwaninga nge-Iberogast® kusikisela ukuthi isekela ukugaya okunempilo ngokusebenzisa izindlela ezihlukahlukene.
I-candytuft ebabalayo ibonakala iyasiza ekuthuthukiseni ithoni ye-muscle ebushelelezi, kuyilapho amanye amakhambi ayisishiyagalombili ebonakala enezakhiwo ze-antispasmodic. Yilezi zenzo ezimbili ezibonakala zichaza ukuthi kungani imithi iwusizo kokubili izimpawu zokugaya ukudla (i-dyspepsia esebenzayo) kanye nezimpawu eziphansi zokugaya ukudla (IBS).
Iberogast® kucatshangwa ukuthi ikhuthaze i-motility (amandla nokuhamba kwemisipha emgodini wokugaya) nokugqugquzela ukukhiqizwa kwe-bile (i-fluid ephethe ukugaya kwamafutha), kanye nokunciphisa ukukhiqizwa kwesisu esiswini.
Ezinye izinzuzo zezempilo ze-Iberogast® ziwukuthi kucatshangwa ukunciphisa igesi lomathumbu, ukuvimbela nokuphulukisa izilonda, nokuba nemiphumela yokulwa ne-antibacterial and nontinflammatory. Kucatshangwa ukuthi iqukethe i-antioxidants futhi ivimbela ama-radicals mahhala .
Ukuthola okuseshweni
EYurophu, ama-ejensi alawulayo anezindinganiso ezingavamile kakhulu zokwelashwa kwamakhemikhali kunabase-United States. Ukwenziwa okunjalo kufanele kuhlangabezane nezimfuneko eziqinile ezinjengemithi yokwelashwa. Lokhu kusho ukuthi kufanele ihlolwe ngezifundo eziphezulu zemitholampilo.
Ngakho i-Iberogast® iye yafundiswa kakhulu ekusebenzeni kwayo nokuphepha ekukhuthazeni impilo yokugaya kokubili ezingxenyeni ezingenhla nezingezansi zegciwane lokugaya. Njengoba kushiwo ngenhla, lezi zimo ezimbili ezisekela kakhulu ucwaningo ziyi-dyspepsia esebenzayo ne-IBS.
Ucwaningo oluningi luye lwabona ukuthi i-Iberogast® inamathuba amaningi kakhulu okusebenza kahle ezimpawu ze-dyspepsia kune-placebo nemiphumela yayo efana nalabo abatholakala emithi yokwelashwa.
Ngokuqondene ne-IBS, isifundo esikhulu, esiphambanisekile, esasisebenzisa i-placebo control group, sathola ukuthi i-Iberogast® yanciphisa kakhulu ubuhlungu besisu nezinye izimpawu ze-IBS uma kuqhathaniswa ne-placebo. Kulesi sifundo, abantu abangu-203 abane-IBS ukuxilongwa basebenzise i-Iberogast® isikhathi esingamaviki amane. Imiphumela yalolu cwaningo ibonisa ukuthi i-Iberogast® iphumelela ekuthuthukiseni izinga lokuphila, ukunciphisa ubuhlungu besisu kanye nezinye izimpawu ze-IBS, kungakhathaliseki ukuthi uhlobo lwe-IBS luhlobo olunjani (isib. Ukuqothulwa okukhulu, isifo sohudo, noma uhlobo oluthile).
Nakuba lolu cwaningo lwaluyisifundo sekhwalithi esiphezulu ngokusetshenziswa kwayo kwe-double blind blind design kanye nokulawulwa kwe-placebo, izifundo ezengeziwe kudingeka ziqhutshwe ukuze zinikeze ubufakazi obengeziwe bokubaluleka kwe-Iberogast® njengekhambi le-IBS.
Ukuphepha
Phakathi neminyaka engamashumi amahlanu edlule, ucwaningo oluningi aluhlolisanga kuphela ukuphumelela kwe-Iberogast®, kodwa nokuphepha kwalo. Ngokujwayelekile, imiphumela emibi evela ekubunjweni ayidlangalaleni. Lokhu kungenxa yokuthi, ngokwengxenye, ukuthi ukubunjwa kusebenza endleleni yokugaya, okungenethonya elincane kwisistimu yezinzwa zomphakathi. Uma kwenzeka imiphumela emibi, engavamile kakhulu, ithatha uhlobo lwezimpawu zokuhlunga okufana nesifo esikhukhulayo, izimpande noma ezinye izikhumba, ukuqhuma, ukuphefumula noma ukuphefumula.
Ngokungafani namanye amalungiselelo ama-herbal, kuye kwaba nobufakazi obuncane bokuthi i-Iberogast® iyingozi kulokhu. Ngakho abacwaningi abaningi baphetha ngokuthi i-Iberogast® iphephile ukusetshenziswa kwesikhathi eside.
Ubani Okungafanele Athathe Iberogast®
Njengomunye umkhiqizo ongenayo yonke, kufanele uhlole njalo nodokotela wakho ukuqinisekisa ukuthi akukho ukuphikisana kwakho ukunikeza i-Iberogast® ukuzama. Kufanele uqiniseke ukuthi udokotela wakho uyamukelwa uma uwela kwesinye sezigaba ezilandelayo:
- Unesifo sesibindi
- Ukhulelwe noma uhlose ukukhulelwa
- Uncelisa
Ingabe i-Iberogast® Safe for Children?
Ucwaningo oluthile lwezibalo luqoqa idatha ngokuphepha nokusebenza kwe-Iberogast® ukuze kusetshenziswe ezinganeni. Ngayinye yalezi zifundo yayinkulu kakhulu, kodwa akekho noyedwa owawuyi-design double, futhi ayizange isebenzise iqembu lokulawula i-placebo. Kodwa-ke, lezi zifundo zokuhlola zibonisa ukuthi i-Iberogast® yayiphumelela kakhulu ekunciphiseni izimpawu zokugaya, kuhlanganise ne-dyspepsia esebenzayo ne-IBS. Akekho emfundweni yembula noma yimiphi imiphumela emibi noma yiziphi izinkinga nge-Iberogast® ezihambisana neminye imithi.
Esinye isifundo esikhulu sasihlola imiphumela ye-Iberogast® esikhathini esingesonto elilodwa ezinganeni ezazitholakale zine-dyspepsia esebenzayo kanye / noma i-IBS. Imiphumela yabona ukwehla okukhulu kwezimpawu zokugaya ukudla. Imiphumela emibi yayingavamile futhi ayiyinto engathí sina, kodwa yayihlanganisa ukuhlukumeza, ukuhlanza nokunyuka kwezihlungu zesisu kanye nezimpawu zokugaya.
Ukuphatha
I-Iberogast® iyinhlangano eluhlaza obomvu ofika ebhodleleni elimnyama elincane ne-dropper. Kumele kuthathwe ngaphambi noma ngesikhathi sokudla.
Ukuze usebenzise i-Iberogast®, kufanele ugubha ibhodlela ngamandla. Ukusebenzisa i-dropper, uzongeza inombolo efanele yamaconsi eklasini lamanzi noma okunye uketshezi. Ngokomkhiqizi, abadala nabantwana abangaphezu kweminyaka engu-12 kufanele bathathe amaconsi angu-20, kathathu ngosuku. Izingane ezineminyaka eyisithupha kuya kwezingu-12 kufanele zithathe amaconsi angu-15 ngosuku, kanti izingane ezineminyaka emihlanu kuya kweyisithupha kufanele zinikezwe amaconsi angu-10, kathathu ngosuku. Izingane ezinezinyanga ezintathu kuya eminyakeni emithathu kufanele zinikezwe amaconsi ayisishiyagalombili ngosuku, kanti izingane ezineminyaka engaphansi kwezinyanga ezintathu kufanele zinikezwe amaconsi ayisithupha ngosuku.
Uma usuke weqa umthamo noma wesaba ukuthi ulahlekelwe umthamo, linda kuze kube sekudla okulandelayo okuhleliwe ukuthi uthathe isilinganiso sakho esilandelayo. Uma ucabanga ukuthi uthathe okuningi, akudingeki ukuba ukhathazeke njengoba kungekho bufakazi bomuntu obhekene nokulimala kokudlula ngokweqile.
Uma wena, noma ingane yakho, uhlangabezana nanoma yimiphi imiphumela emibi, yeka ukusebenzisa i-Iberogast® bese utshela udokotela wakho.
Izwi elivela
I-IBS iyimpilo enhlalakahle engenamakhetho okulinganiselwe okwelashwa okuphumelelayo. Esikhathini esidlule, odokotela baye baba nomuthi olinganiselwe wemithi yokunikeza iziguli zabo ze-IBS. Imithi enjalo ihloselwe izibonakaliso ezithile ze-IBS. Muva nje, imishanguzo emisha ifinyelele emakethe eyenzelwe ngokuqondile njengezokwelapha ze-IBS. Kodwa-ke, bambalwa abantu abathola ukuphumula okugcwele kwezibonakaliso kule mithi. Kukhona ukwelashwa kokudla kwe-IBS, ukudla okungezansi kwe-FODMAP , engasebenza nginingi labantu abazama, kodwa kunzima ukunamathela.
Njengoba kunikezwe isikhathi eside se-IBS, kanye nokulinganiselwa kwezinketho zokwelapha ezichazwe esigabeni esandulele, i-Iberogast® ibonakala iyindlela ekhangayo kubantu abafuna ukuphatha lesi sifo. Lokhu kungase kube yiqiniso ikakhulu kubantu abaningi abakwa-IBS abasiyo kuphela isimo sokugaya abasisebenzisayo, ikakhulukazi uma esinye isimo singumsebenzi we-dyspepsia. Uma umqondo wokulungiswa kwamakhemikhali obonakala usebenza kahle futhi lokho kungabangela imiphumela emibi kakhulu emibi kuwe, cela udokotela wakho ukuthi i-Iberogast® ingaba yini ukungenelela okufanelekile kuwe.
> Imithombo:
> Grundmann O, Yoon S. "Imithi ehambisanayo neyehlukile e-irritable bowel syndrome: Umbono ohlangene" World Journal of Gastroenterology 2014 20 (2): 346-362.
> "Iberogast Consumer Brochure®" June 2015.
> Madisch A, Holtmann G, Plein K, Hotz J. "Ukwelashwa kwesifo sofuba esingenasisindo ngamalungiselelo omuthi: imiphumela ye-double-blind, i-randomised, i-placebo-elawulwa yi-multi-center trial" i- Alimentary Pharmacology & Therapeutics 2004 19; 3: 271-279.
> U-Ottillinger B, uSorr M, i-Malfertheiner P, i-Allescher A. "I-STW 5 (i-Iberogast®) -izinga eliphephile futhi eliphumelelayo ekwelapheni ukuphazamiseka kwezinsizakalo zokusebenza" i- Wien Med Wochenschr 2013 163; 3-4: 65-72.